These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 29393377)
1. BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway. Gu Y; Li A; Sun H; Li X; Zha H; Zhao J; Xie J; Zeng Z; Zhou L Int J Mol Med; 2018 May; 41(5):2660-2668. PubMed ID: 29393377 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2. Shan H; Zhou X; Chen C Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
4. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway. Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685 [TBL] [Abstract][Full Text] [Related]
5. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation. Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway. Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126 [TBL] [Abstract][Full Text] [Related]
7. Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells. Wang H; Duan L; Zou Z; Li H; Yuan S; Chen X; Zhang Y; Li X; Sun H; Zha H; Zhang Y; Zhou L Int J Med Sci; 2014; 11(8):841-9. PubMed ID: 24936148 [TBL] [Abstract][Full Text] [Related]
8. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway. Hu F; He Z; Sun C; Rong D Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways. Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786 [TBL] [Abstract][Full Text] [Related]
11. SPAG5 promotes the proliferation, migration, invasion, and epithelial-mesenchymal transformation of colorectal cancer cells by activating the PI3K/AKT signaling pathway. Zhang X; Wu W; Li X; He F; Zhang L Chin J Physiol; 2023; 66(5):365-371. PubMed ID: 37929348 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression. Qin A; Qian W Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533 [TBL] [Abstract][Full Text] [Related]
13. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway. Yin F; Huang X; Xuan Y Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways. Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of Lgr6 inhibits proliferation and invasion and increases apoptosis in human colorectal cancer. Wang F; Dai CQ; Zhang LR; Bing C; Qin J; Liu YF Int J Mol Med; 2018 Jul; 42(1):625-632. PubMed ID: 29693156 [TBL] [Abstract][Full Text] [Related]
16. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways. Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481 [TBL] [Abstract][Full Text] [Related]
17. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway. Li Y; Peng F; Tan X; Wang J; Xu Y Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976 [TBL] [Abstract][Full Text] [Related]
18. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway. Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566 [TBL] [Abstract][Full Text] [Related]
19. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer. Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y Gene; 2022 Apr; 819():146240. PubMed ID: 35114275 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]